Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma

Valérie Boige(Institut Gustave Roussy), Françoise Farace(Inserm)
The Oncologist
June 15, 2012
10.1634/theoncologist.2011-0465
Cited by 132

Related Papers

Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model
|Nature Communications|2020|80
Targeting genome integrity dysfunctions impedes metastatic potency in non–small cell lung cancer circulating tumor cell–derived explants
|JCI Insight|2022|43
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study
|Oncotarget|2016|36